WAM
ONCE

Wealthspire Advisors (Maryland)’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-120
Closed -$14K – 2435
2019
Q1 		$14K Sell
120
-180
-60% -$13.2K ﹤0.01% 1415
2018
Q4 		$12K Sell
300
-21
-7% -$911 ﹤0.01% 1412
2018
Q3 		$18K Buy
321
+21
+7% +$1.44K ﹤0.01% 1355
2018
Q2 		$25K Hold
300
– – ﹤0.01% 1233
2018
Q1 		$20K Hold
300
– – ﹤0.01% 1307
2017
Q4 		$15K Hold
300
– – ﹤0.01% 1444
2017
Q3 		$27K Hold
300
– – ﹤0.01% 1201
2017
Q2 		$18K Buy
+300
New +$16.8K ﹤0.01% 1317

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s ONCE Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q2 2019, closing a stake of 120 shares — an estimated $14K sold.

Wealthspire Advisors (Maryland) first reported a position in ONCE in Q2 2017 and held it in 8 quarters. The position peaked at $27K in Q3 2017. 194 funds tracked by Wall St. Rank hold ONCE as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 120 Spark Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $14K.
  • Wealthspire Advisors (Maryland) first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2017 and held it in 8 quarters.
  • Wealthspire Advisors (Maryland)'s Spark Therapeutics, Inc. Common Stock position peaked at $27K in Q3 2017.
  • 194 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.